Avian Influenza Vaccine Market Size, Share, Growth Analysis, By Strain(H5, H7, and H9), By Application(Chicken, Turkey, and Goose & Duck), By Region - Industry Forecast 2024-2031

The global avian influenza vaccine market is dominated by Asia Pacific. This can be attributed to increased poultry production and increasing outbreaks of bird flu in the region. China produced 13,900 thousand metric tons of poultry meat in 2022, according to a recent Foreign Agricultural Service/USDA report, it is estimated that the U.S. will exhibit significant market growth due to growing meat and poultry industry, increasing animal health expenditure.

Asia-Pacific is expected to register a steady revenue CAGR over the forecast period due to higher R&D activities, higher incidence of liver diseases, unmet medical needs and investments due to the region’s increasing healthcare industry.

North America is the fastest growing region in the market. They export poultry, poultry and various meat products. Increasing government support to raise awareness of the avian influenza virus and improve efficiency of the avian influenza vaccine is also having a positive impact on market growth. North America is expected to record the highest revenue share in the global market due to increasing R&D expenditure in the form of lucrative payment plans, pharmaceutical companies and R&D institutes is due to new medicines and important people in the region.